Literature DB >> 32486268

License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity.

Angélica Díaz-Basabe1,2, Francesco Strati1, Federica Facciotti1.   

Abstract

Invariant Natural Killer T (iNKT) cells are a non-conventional, innate-like, T cell population that recognize lipid antigens presented by the cluster of differentiation (CD)1d molecule. Although iNKT cells are mostly known for mediating several immune responses due to their massive and diverse cytokine release, these cells also work as effectors in various contexts thanks to their cytotoxic potential. In this Review, we focused on iNKT cell cytotoxicity; we provide an overview of iNKT cell subsets, their activation cues, the mechanisms of iNKT cell cytotoxicity, the specific roles and outcomes of this activity in various contexts, and how iNKT killing functions are currently activated in cancer immunotherapies. Finally, we discuss the future perspectives for the better understanding and potential uses of iNKT cell killing functions in tumor immunosurveillance.

Entities:  

Keywords:  CD1d; cancer; cytotoxicity; iNKT; infections

Year:  2020        PMID: 32486268     DOI: 10.3390/ijms21113909

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  9 in total

Review 1.  Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System.

Authors:  Ana Belén Herrera-Campos; Esteban Zamudio-Martinez; Daniel Delgado-Bellido; Mónica Fernández-Cortés; Luis M Montuenga; F Javier Oliver; Angel Garcia-Diaz
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

Review 2.  Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.

Authors:  Nilberto Dias de Araújo; Fábio Magalhães Gama; Mateus de Souza Barros; Thaís Lohana Pereira Ribeiro; Fabíola Silva Alves; Lilyane Amorim Xabregas; Andréa Monteiro Tarragô; Adriana Malheiro; Allyson Guimarães Costa
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

3.  CD138 expression is a molecular signature but not a developmental requirement for RORγt+ NKT17 cells.

Authors:  Shunqun Luo; Juntae Kwon; Assiatu Crossman; Pyong Woo Park; Jung-Hyun Park
Journal:  JCI Insight       Date:  2021-09-22

4.  Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.

Authors:  Chien-Ya Hsu; Yu-Shan Chueh; Ming-Ling Kuo; Pei-Tzu Lee; Hsiu-Shan Hsiao; Jing-Long Huang; Syh-Jae Lin
Journal:  PLoS One       Date:  2021-12-22       Impact factor: 3.240

Review 5.  The iNKT Cell-Macrophage Axis in Homeostasis and Disease.

Authors:  Mariana S Cruz; José Pedro Loureiro; Maria J Oliveira; Maria Fatima Macedo
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  Prenatal antibiotics exposure does not influence experimental allergic asthma in mice.

Authors:  Imke Lingel; Adrienne N Wilburn; Julie Hargis; Jaclyn W McAlees; Yves Laumonnier; Claire A Chougnet; Hitesh Deshmukh; Peter König; Ian P Lewkowich; Inken Schmudde
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

7.  Human iNKT Cells Modulate Macrophage Survival and Phenotype.

Authors:  J Pedro Loureiro; Mariana S Cruz; Ana P Cardoso; Maria J Oliveira; M Fátima Macedo
Journal:  Biomedicines       Date:  2022-07-17

8.  Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors.

Authors:  Yan-Ruide Li; Yang Zhou; Matthew Wilson; Adam Kramer; Ryan Hon; Yichen Zhu; Ying Fang; Lili Yang
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

Review 9.  Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies.

Authors:  Yan-Ruide Li; Zachary Spencer Dunn; Yang Zhou; Derek Lee; Lili Yang
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.